Clinical and experimental obstetrics & gynecology 2012-01-01

Holoprosencephaly in clomiphene-induced pregnancy: a possible association? A case report and literature review.

G Eleftheriou, R Butera, L Manzo

Index: Clin. Exp. Obstet. Gynecol. 39(4) , 535-6, (2012)

Full Text: HTML

Abstract

Clomiphene is widely used for inducing ovulation. Evidence for congenital abnormalities, in particular central nervous system defects (CNS-D) and in babies born from clomiphene-induced pregnancies is conflicting. The authors report a case of holoprosencephalia (HPE) in a fetus delivered from a mother receiving clomiphene.

Related Compounds

Related Articles:

Aberrant endocrinology and ovarian response to clomiphene citrate during the course of an undiagnosed early intrauterine pregnancy: a case report.

2013-01-01

[J. Reprod. Med. 58(5-6) , 256-60, (2013)]

[Current approach to therapy for male infertility in patients with varicocele].

2012-01-01

[Ter. Arkh. 84(10) , 56-61, (2012)]

Probability of success of conservative treatment of infertility: exact timing as an important prognostic factor.

2013-01-01

[J. Reprod. Med. 58(5-6) , 205-11, (2013)]

Modified repeated intracyclic clomiphene citrate therapy after conventional clomiphene therapy.

2012-01-01

[Clin. Exp. Obstet. Gynecol. 39(3) , 317-20, (2012)]

Sequential clomiphene citrate/hMG versus hMG for ovulation induction in clomiphene citrate-resistant women.

2013-03-01

[Arch. Gynecol. Obstet. 287(3) , 591-7, (2013)]

More Articles...